Forskning
Udskriv Udskriv
Switch language
Hvidovre Hospital - en del af Københavns Universitetshospital
Udgivet

Prognostic significance of chronic respiratory symptoms in individuals with normal spirometry

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. NORDSTAR - Paving the way for a new era in asthma research

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. ERS and tobacco harm reduction

    Publikation: Bidrag til tidsskriftLederForskning

  3. Fertility treatment among women with asthma - A case-control study of 3689 women with live births

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Computed tomography quantification of emphysema in people living with HIV and uninfected controls

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Pulmonary Arterial Enlargement in Well-Treated Persons With Human Immunodeficiency Virus

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Sex differences between women and men with COPD: A new analysis of the 3CIA study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Interstitial lung abnormalities in people with HIV infection and uninfected controls

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. ERS and tobacco harm reduction

    Publikation: Bidrag til tidsskriftLederForskning

Vis graf over relationer

Normal spirometry is often used to preclude airway disease in individuals with unspecific respiratory symptoms. We tested the hypothesis that chronic respiratory symptoms are associated with respiratory hospitalisations and death in individuals with normal spirometry without known airway disease.We included 108 246 randomly chosen individuals aged 20-100 years from a Danish population-based cohort study. Normal spirometry was defined as a pre-bronchodilator forced expiratory volume in 1 s/forced vital capacity ratio ≥0.70. Chronic respiratory symptoms included dyspnoea, chronic mucus hypersecretion, wheezing and cough. Individuals with known airway disease, i.e. chronic obstructive pulmonary disease and/or asthma, were excluded (n=10 291). We assessed risk of hospitalisations due to exacerbations of airway disease and pneumonia, and respiratory and all-cause mortality, from 2003 through 2018.52 999 individuals had normal spirometry without chronic respiratory symptoms and 30 890 individuals had normal spirometry with chronic respiratory symptoms. During follow-up, we observed 1037 hospitalisations with exacerbation of airway disease, 5743 hospitalisations with pneumonia and 8750 deaths, of which 463 were due to respiratory disease. Compared with individuals with normal spirometry without chronic respiratory symptoms, multivariable adjusted hazard ratios for individuals with normal spirometry with chronic respiratory symptoms were 1.62 (95% CI 1.20-2.18) for exacerbation hospitalisations, 1.26 (95% CI 1.17-1.37) for pneumonia hospitalisations, 1.59 (95% CI 1.22-2.06) for respiratory mortality and 1.19 (95% CI 1.13-1.25) for all-cause mortality. There was a positive dose-response relationship between number of symptoms and risk of outcomes. Results were similar after 2 years of follow-up, for never-smokers alone, and for each symptom separately.Chronic respiratory symptoms are associated with respiratory hospitalisations and death in individuals with normal spirometry without known airway disease.

OriginalsprogEngelsk
TidsskriftThe European Respiratory Journal
Vol/bind54
Udgave nummer3
ISSN0903-1936
DOI
StatusUdgivet - sep. 2019

Bibliografisk note

Copyright ©ERS 2019.

ID: 59309599